
Role of metabolic syndrome components in HIV-associated sensory neuropathy
Author(s) -
Beau M. Ances,
Florin Vaida,
Debralee Rosario,
Jennifer Marquie-Beck,
Ronald J. Ellis,
David M. Simpson,
David B. Clifford,
Justin C. McArthur,
Igor Grant,
J. Allen McCutchan
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328332204e
Subject(s) - sensory neuropathy , medicine , human immunodeficiency virus (hiv) , sensory system , peripheral neuropathy , metabolic syndrome , sida , viral disease , dermatology , immunology , biology , neuroscience , diabetes mellitus , endocrinology , obesity
Sensory neuropathy is a common peripheral nerve complication of HIV infection and highly active antiretroviral therapy. Metabolic syndrome (MetS), a cluster of risk factors for atherosclerosis and microvascular disease, is associated with sensory neuropathy in HIV-uninfected (HIV-negative) persons. We examined whether MetS or its components predispose individuals to HIV-associated sensory neuropathy (HIV-SN).